Peripheral blood eosinophilia is a well recognised feature of Hodgkin's disease, as is an eosinophilia infiltrate of the disease in lymph nodes and tissues.'
In this study we evaluated the distribution and clinical importance of blood eosinophilia in 1260 patients with Hodgkin's disease who had been entered into British National Lymphoma Investigation (BNLI)2 clinical studies. Patients with eosinophilia were subdivided into two groups: those with a selective eosinophilia and those in whom the eosinophilia was an element of generalised leucocytosis.
Material and methods
The absolute eosinophilia count at presentation was derived from the total white cell count and differential and was available for 1260 patients entered into the BNLI Hodgkin's disease studies over the past 14 years. A raised eosinophil count was taken as greater than 0-44 x 109/l, and a raised total white cell count as greater than 11 x I09/l. Eosinophilia associated with a raised total white cell count was taken as an element of general leucocytosis, unless the raised Accepted for publication 16 September 1986 count was due solely to the eosinophilia. Survival curves were calculated by the life table method, and statistical comparison of curves carried out by the log rank test, as described by Peto et al3 and by the Mantel test. 4 The histopathological subtyping of the patients had previously been determined by the method of Bennett et al. ' -7 Results One hundred and ninety three (15%) of the 1260 patients with a recorded eosinophil count had an eosinophilia at presentation. Fig 1 shows the distribution of the eosinophil count. In over 50% of the cases of eosinophilia the count was > 0-6 x 109/L. The survival of these patients was found to be significantly greater than that of the remainder (X2 = 5 0, fig 2) . Of the 193 patients with an eosinophilia, this was part of a general leucocytosis in 98 (51%). In the remaining 95 patients the eosinophilia was selective in that it was associated with a normal total white cell count, or with a raised count due solely to the eosinophilia (two patients). Eosinophilia as part of a general leucocytosis was found to confer no survival advantage (X2 = 0o0), whereas selective eosinophilia showed a clear and significant advantage (x2 = 8-2, p < 0 01, fig 3) . Of the 17 deaths in patients with a selective eosinophilia, four were intercurrent (all in patients with advanced stage and grade I nodular sclerotic histology).
This improved prognosis associated with a selective eosinophilia was present in patients with localised dis- the incidence of eosinophilia (selective and nonselective) was slightly higher in patients with nodular sclerosis, but the incidence of selective eosinophilia was similar in all groups.
With regard to the selective eosinophilias, the survival advantage was found to be confined to patients with mixed cellularity disease (X2 = 3-8) and grade I nodular sclerosis (X2 = 6 1). No improved survival was apparent in patients with grade II nodular sclerosis, nor in those with lymphocyte predominance, though the number of patients in the latter group was small.
Further analysis of the series was made to determine where the prognostic advantage of selective eosinophilia lay in relation to treatment. No significant difference was found between the complete remission rates and relapse free curves of patients with and without selective eosinophilia, nor between the survivals of patients who failed to obtain complete remission after their initial treatment. There was, however, a considerable and significant difference between the survival of patients with and without selective eosinophilia in those who had relapsed after attaining complete remission from their initial treatment (X2 = 4.4).
Discussion
The incidence of eosinophilia at presentation in this very large series of patients with Hodgkin's disease was 15%, which is in agreement with previous estimates.8 In patients with an eosinophilia this was selective in almost half (49%) and was part of a general leucocytosis in the remaining 51%. Eosinophilia in general was associated with a minor survival advantage, but the survival advantage for patients with selective eosinophilia was 
